Current report filing

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Cash flows from operating activities:      
Net (loss) income $ (281,704) $ 80,310 $ 59,621
Net loss (income) from discontinued operations 335,984 (49,190) (54,368)
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 65,333 61,244 58,585
Amortization 11,593 13,537 13,603
Amortization of deferred financing costs and original issue discount 2,515 2,799 3,252
Debt extinguishment costs 22,658 3,400 5,627
Foreign currency exchange (gain) loss (5,264) 1,228 13,910
Pension and postretirement healthcare benefit expense 416 1,471 742
Pension and postretirement healthcare benefit funding (3,264) (4,955) (2,412)
Deferred income tax (benefit) provision (60,060) 3,898 1,863
Net loss on asset disposals 4,722 4,559 10,350
Stock compensation 17,194 13,281 16,899
Equity in net income from affiliated companies (21,065) (45,808) (37,318)
Dividends received from affiliated companies 40,000 40,000 40,000
Gain on contract termination 0 0 (20,612)
Other, net (3,478) (3,185) 1,369
Working capital changes that provided (used) cash, excluding the effect of acquisitions and dispositions:      
Receivables 6,971 4,486 (3,154)
Inventories (2,976) (4,226) (1,586)
Prepaids and other current assets (1,359) 2,883 (1,703)
Accounts payable 6,868 541 (3,890)
Accrued liabilities 5,015 6,903 11,315
Net cash provided by operating activities, continuing operations 140,099 133,176 112,093
Net cash provided by operating activities, discontinued operations 83,499 134,587 136,551
Net cash provided by operating activities 223,598 267,763 248,644
Cash flows from investing activities:      
Purchases of property, plant and equipment (51,598) (52,537) (55,128)
Investment in affiliated companies     (5,000)
Cash flows from financing activities:      
Draw down of revolving credit facilities 126,500 175,500 108,500
Repayments of revolving credit facilities (126,500) (175,500) (133,500)
Issuance of long-term debt, net of original issue discount and financing fees 640,340   1,267,000
Debt issuance costs (8,987)   (6,395)
Repayments of long-term debt (1,091,134) (215,000) (1,367,959)
Debt prepayment fees (10,550)    
Dividends paid to stockholders (243,749)    
Repurchases of common shares (4,598) (3,563) (2,920)
Proceeds from stock options exercised 373 3,975  
Other, net (1,875) (155) 132
Net cash used in financing activities, continuing operations (720,180) (214,743) (135,142)
Net cash used in financing activities, discontinued operations (2,640) (1,350) (2,083)
Net cash used in financing activities (722,820) (216,093) (137,225)
Proceeds from business divestiture, net of cash and indebtedness 624,256    
Proceeds from sale of assets 2,375    
Other, net   469 557
Net cash provided by (used in) investing activities, continuing operations 575,033 (52,068) (59,571)
Net cash (used in) provided by investing activities, discontinued operations (23,561) 16,709 (59,719)
Net cash provided by (used in) investing activities 551,472 (35,359) (119,290)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 11,052 (2,120) 354
Net change in cash, cash equivalents and restricted cash 63,302 14,191 (7,517)
Cash, cash equivalents and restricted cash at beginning of period 73,917 59,726 67,243
Cash, cash equivalents and restricted cash at end of period 137,219 73,917 59,726
Less cash, cash equivalents and restricted cash of discontinued operations (22,202) (36,505) (30,966)
Cash, cash equivalents and restricted cash at end of period of continuing operations $ 115,017 $ 37,412 $ 28,760